The trademark application NIRAGIN was filed by Bausch Health Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on July 14, 2022, and it was registered by office on October 21, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1683513 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).